Aileron Therapeutics, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$0.31 | -$0.31 | -$0.31 |
| Q2 2024 | 1 | -$0.25 | -$0.25 | -$0.25 |
| Q3 2024 | 1 | -$0.18 | -$0.18 | -$0.18 |
| Q1 2025 | 1 | -$0.21 | -$0.21 | -$0.21 |
| Q2 2025 | 1 | -$0.24 | -$0.24 | -$0.24 |
| Q3 2025 | 1 | -$0.28 | -$0.28 | -$0.28 |
| Q4 2025 | 1 | -$0.22 | -$0.22 | -$0.22 |
Aileron Therapeutics, Inc. Earnings Date And Information
Aileron Therapeutics, Inc. last posted its earnings results on Thursday, November 14th, 2024. The company reported $-0.27 earnings per share for the quarter, missing analysts' consensus estimates of $-0.25 by $0.02. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Aileron Therapeutics, Inc. has generated $-3 earnings per share over the last year ($-3.42 diluted earnings per share) and currently has a price-to-earnings ratio of -1.83. Aileron Therapeutics, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 27th, 2025 based on prior year's report dates.
Aileron Therapeutics, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/14/2024 | Q3 2024 | -$0.25 | -$0.27 | -0.02 | $0 | $0 |
| 08/14/2024 | Q2 2024 | -$0.25 | -$0.45 | -0.2 | $0 | $0 |
| 05/15/2024 | Q1 2024 | -$0.86 | $0 | |||
| 04/29/2024 | Q4 2023 | -$1.54 | $134,000 | |||
| 10/13/2023 | Q3 2023 | -$0.40 | $0 | |||
| 08/11/2023 | Q2 2023 | -$0.39 | $0 | |||
| 05/08/2023 | Q1 2023 | -$0.86 | -$1.00 | -0.14 | $0 | |
| 04/28/2023 | Q4 2022 | -$0.97 | $0 | |||
| 11/01/2022 | Q3 2022 | -$1.60 | -$1.40 | 0.2 | $0 | |
| 08/15/2022 | Q2 2022 | -$1.80 | -$1.75 | 0.05 | $0 | |
| 05/05/2022 | Q1 2022 | -$1.60 | -$1.86 | -0.26 | $0 | |
| 03/28/2022 | Q4 2021 | -$1.60 | -$1.50 | 0.1 | $0 | |
| 11/12/2021 | Q3 2021 | -$1.40 | -$1.48 | -0.08 | $0 | |
| 08/11/2021 | Q2 2021 | -$1.40 | -$1.26 | 0.14 | $0 | |
| 05/11/2021 | Q1 2021 | -$1.20 | -$1.67 | -0.47 | $0 | |
| 03/24/2021 | Q4 2020 | -$2.20 | -$2.69 | -0.49 | $0 | |
| 11/12/2020 | Q3 2020 | -$2.00 | -$2.55 | -0.55 | $0 | |
| 08/05/2020 | Q2 2020 | -$3.20 | -$2.81 | 0.39 | $0 | |
| 05/11/2020 | Q1 2020 | -$4.00 | -$4.85 | -0.85 | $0 | |
| 03/30/2020 | Q4 2019 | -$5.40 | -$5.20 | 0.2 | $0 |
Aileron Therapeutics, Inc. Earnings: Frequently Asked Questions
-
When is Aileron Therapeutics, Inc.'s earnings date?
Aileron Therapeutics, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 27th, 2025 based off last year's report dates.
-
How can I listen to Aileron Therapeutics, Inc.'s earnings conference call?
The conference call for Aileron Therapeutics, Inc.'s latest earnings report can be listened to online.
-
How can I read Aileron Therapeutics, Inc.'s conference call transcript?
The conference call transcript for Aileron Therapeutics, Inc.'s latest earnings report can be read online.
-
How much profit does Aileron Therapeutics, Inc. generate each year?
Aileron Therapeutics, Inc. (:ALRN) has a recorded net income of $0. Aileron Therapeutics, Inc. has generated $-3.42 earnings per share over the last four quarters.
-
What is Aileron Therapeutics, Inc.'s price-to-earnings ratio?
Aileron Therapeutics, Inc. (:ALRN) has a price-to-earnings ratio of -1.83 and price/earnings-to-growth ratio is -0.46.
